课题基金 / 基金详情

Red Cell Transfusion and In-hospital Mortality: Impact of Age of Red Cells and ABO Blood Group

Red Cell Transfusion and In-hospital Mortality: Impact of Age of Red Cells and ABO Blood Group
红细胞输注和院内死亡率:红细胞年龄和 ABO 血型的影响
批准号:
181862
负责人:
Eikelboom John W
金额:
$16.14万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-03-01 至 2012-03-01

项目摘要

项目成果

Eikelboom John W的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Blood transfusion can be life-saving but there is increasing evidence that it might also be harmful in some patients. Red blood cells undergo changes during storage that could lead to harmful effects. Most of the studies performed to date have been small
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Coronavirus Therapy (ACT) to prevent COVID-19 disease progression: a clinical trial platform
  • 批准号:
    429561
  • 项目类别:
    Operating Grants
  • 资助金额:
    $213.97万
  • 财政年份:
    2020
  • 负责人:
    Eikelboom John W
  • 依托单位:
Reducing the burden of bleeding and cardiovascular complications of bleeding
  • 批准号:
    369170
  • 项目类别:
    Operating Grants
  • 资助金额:
    $201.69万
  • 财政年份:
    2017
  • 负责人:
    Eikelboom John W
  • 依托单位:
Informing Fresh versus Old Red Cell Management (INFORM): A large simple phase III randomized controlled trial
  • 批准号:
    238844
  • 项目类别:
    Operating Grants
  • 资助金额:
    $117.02万
  • 财政年份:
    2011
  • 负责人:
    Eikelboom John W
  • 依托单位:
Informing Fresh versus Old Red Cell Management (INFORM): A large simple phase III randomized controlled trial
  • 批准号:
    238484
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2011
  • 负责人:
    Eikelboom John W
  • 依托单位:
海外基金